# BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

> **NCT00097357** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 1238 (actual)

## Conditions studied

- Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Enoxaparin
- **DRUG:** Warfarin
- **DRUG:** Enoxaparin Placebo
- **DRUG:** Apixaban Placebo

## Key facts

- **NCT ID:** NCT00097357
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 1238 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097357, "BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00097357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*